menu
In Vitro Diagnostics And IVD Quality Control Industry Reaching Nearly USD 114.73 Billion By 2030
The global In Vitro Diagnostics (IVD) and IVD quality control markets combine to account for USD 112.79 billion in revenue in 2021, which is expected to reach USD 114.73 billion by 2030, growing at a cumulative rate of 0.2% over the forecast period.

In Vitro Diagnostics And IVD Quality Control Industry Data Book Covers In Vitro Diagnostics & IVD Quality Control Markets.

The global In Vitro Diagnostics (IVD) and IVD quality control markets combine to account for USD 112.79 billion in revenue in 2021, which is expected to reach USD 114.73 billion by 2030, growing at a cumulative rate of 0.2% over the forecast period.

Grand View Research’s In Vitro Diagnostics and IVD quality control industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, volumetric analyses, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.

In Vitro Diagnostics Market Insights

The global in vitro diagnostic market size was valued at USD 132.95 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of -2.8 % from 2023 to 2030.

The reagents products segment led the global market in 2022 and accounted for the largest revenue share of more than 65.00%. The region is expected to retain its dominance growing at the second-fastest CAGR during the forecast period owing to the extensive R&D initiatives being undertaken by major market players for the development of novel reagents.

The growth in precision medicine is projected to enhance the overall demand for such novel reagents and consumables. Players are aligning their instrument launches in line with the increasing genetic test requirement globally.

The molecular diagnostics application segment held the highest market share of 40.92% in 2022 owing to the launch of novel products and continuous evolution in technology. Although PCR usually needs complex equipment, research efforts in this segment have given rise to innovations, such as plasmofluidic chips, which are the size of a postage stamp.

Based on end-uses, the global market has been further sub-segmented into hospitals, laboratories, home care, and others. The laboratory end-use segment led the global market in 2022 and accounted for the highest revenue share of more than 41.00%. An increase in awareness about personalized medicine, a rise in demand for affordable services, and technological advancements are some of the key factors expected to boost the growth of the laboratory segment.

The point-of-care test location segment held the largest revenue share of more than 20.75% in 2022. The demand for point-of-care tests and devices is rising owing to the increased demand for rapid identification of diseases in close proximity to patients to facilitate faster decision-making. This trend is pushing the manufacturers to launch small, transportable, fast, and easy-to-use instruments, making use of these instruments easier in non-laboratory settings.

The infectious disease application segment held the highest market share of 63.66% in 2022. IVDs enable the detection of microorganisms that cause infectious diseases. The most common life-threatening infections are HIV/AIDS, tuberculosis, hepatitis, and pneumonia. Furthermore, key market players are entering into a collaboration to improve access to high-quality, innovative laboratory services for patients & healthcare providers.

Access the Global In Vitro Diagnostics And IVD Quality Control Industry Data Book, 2022 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competition benchmarking, macro-environmental analyses, and regulatory & technological framework studies

IVD Quality Control Market Insights

The global In-Vitro Diagnostics quality control market size was valued at USD 905 million in 2018 and is anticipated to register a CAGR of 4.1% over the forecast period.

The immunology application segment led the global market in 2018. Immunology includes the study of the molecular mechanism for understanding the function of the immune system. It majorly involves the mechanism of action of antigens, antibodies, and their interactions. Key applications of the immunochemistry include detection of infectious microorganisms, such as viruses, bacteria, and fungus, by detecting the presence of their toxins and coat antigens.

Molecular diagnostics is anticipated to be the fastest-growing segment at a CAGR of 5.2% over the forecast period. It is a set of complex tests for a medical diagnosis for all major viral, bacterial, and parasitic infections. The introduction of advanced technologies, such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), has helped overcome the drawbacks of traditional systems.

Quality Control (QC) was the largest revenue-generating segment in 2018 and is anticipated to be the fastest-growing segment over the forecast period. IVDs fall under the category of medical devices and, hence, are regulated for quality by the FDA. In U.S. QC refers to the procedures monitoring work processes, detecting problems, and making corrections before delivery of products or services. 

Hospitals segment was the largest end-use segment in 2018 and is likely to retain the position in the future owing to a rising number of admissions and better reliability of healthcare professionals on clinical diagnosis for deciding treatment alternatives. Hospitals have a separate department for diagnostic services. The tests and instruments in this department need to be monitored regularly, which will augment the market growth.

In Vitro Diagnostics And IVD Quality Control Market – Global Industry Segmentation

 

In Vitro Diagnostics And IVD Quality Control Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

 

  • Instruments
  • Reagents
  • Services

In Vitro Diagnostics And IVD Quality Control - Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • Immunoassay
  • Hematology
  • Clinical Chemistry
  • Molecular Diagnostics
  • Coagulation
  • Microbiology
  • Others

In Vitro Diagnostics And IVD Quality Control Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • Infectious Disease
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Disease
  • Drug Testing
  • Others

In Vitro Diagnostics And IVD Quality Control Market - Segment Analysis, By End-use, 2018 - 2030 (USD Million)

  • Hospitals
  • Laboratories
  • Home Care
  • Others

In Vitro Diagnostics And IVD Quality Control Market - Segment Analysis, By Test Location, 2018 - 2030 (USD Million)

  • Point of Care
  • Home Care
  • Others

In Vitro Diagnostics And IVD Quality Control Market - Segment Analysis, By IVD Quality Control Services, 2018 - 2030 (USD Million)

  • Quality Controls
     
     
    1. Clinical Chemistry
    2. Immunochemistry
    3. Hematology
    4. Molecular Diagnostics
    5. Coagulation
    6. Microbiology
    7. Others
  • Quality Assurance Services
     
     
    1. Clinical Chemistry
    2. Immunochemistry
    3. Hematology
    4. Molecular Diagnostics
    5. Coagulation
    6. Microbiology
    7. Others
  • Data Management
     
     
    1. Clinical Chemistry
    2. Immunochemistry
    3. Hematology
    4. Molecular Diagnostics
    5. Coagulation
    6. Microbiology
    7. Others

 

Order your copy of the Free Sample of “In Vitro Diagnostics And IVD Quality Control Industry Data Book - In Vitro Diagnostics & IVD Quality Control Market Size, Share, Trends Analysis, And Segment Forecasts, 2022 - 2030” Data Book, published by Grand View Research

In Vitro Diagnostics And IVD Quality Control Industry Data Book Regional Outlook

  • North America
    1. U.S.
    2. Canada
  • Europe
    1. U.K.
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Russia
  • Asia Pacific
    1. China
    2. Japan
    3. India
    4. South Korea
    5. Singapore
    6. Australia
  • Latin America
    1. Brazil
    2. Mexico
    • Argentina
  • Middle East & Africa (MEA)
    1. South Africa
    • United Arab Emirates
    • Saudi Arabia

In Vitro Diagnostics And IVD Quality Control Industry Data Book Competitive Landscape

Additionally, these players are large and established and hence can innovate to sustain a competitive edge. This in turn offers the leading players to capitalize on consolidation opportunities in the market.

Key players operating in the in vitro diagnostics and IVD quality control industry are –

  • Una Health Ltd.
  • Diachel Diagnostics S.A.
  • BHR Diagnostics Pvt. Ltd.
  • MD Doctors Direct GmbH
  • Axon Lab AG
  • Rafer, S.L.
  • CTK Biotech, Inc.
  • Diagnostic BioSystems
  • Scientific Equipment Company
  • Stat Services Inc.

Go through the table of content of In Vitro Diagnostics And IVD Quality Control Industry Data Book to get a better understanding of the Coverage & Scope of the study

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/sector-reports-list

Follow Us: LinkedIn | Twitter